The Frontiers in Oncology lecture series brings outstanding investigators involved in cancer research to the UMGCC campus each month. The series is designed to educate and provide exposure to the latest developments in cancer biology, treatment and diagnosis. It will be of interest to faculty members, oncologists, medical interns, nurses, pharmacologists, and research fellows.
|When:||3rd Wednesday of every month, 8:00 a.m.|
University of Maryland Health Science Facility II (HSF II) Auditorium
(except November in Hosick Hall)
|CME Credit:||One (1)|
|September 16, 2009||
Marius Sudol, Ph.D.
"From Src Oncogene to WW Domain: Deciphering the HIPPO Tumor Suppressor Pathway in Mammals"
At right: Dr. Antonio Passaniti (sponsor), Dr. Marius Sudol, and Dr. Kevin Cullen
Yang-Xin Fu, M.D., Ph.D.
Dr. Fu's presentation was entitled "The Therapeutic Effect of anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity" and he presented on Wednesday, October 21, 2009.
At right: Dr. Scott Strome, and Dr. Yan-Xin Fu
Merrill J. Egorin, M.D., FACP
"Oral Chemotherapy: Issues That My Generation of Oncologists Never Had to Think About"
At right: Dr. Merrill Egorin and Dr. Douglas Ross (sponsor)
Danny R. Welch, Ph.D.
At right: Dr. Anne Hamburger (sponsor), Dr. Danny Welch, and Dr. Dhan Kalvakolanu
|January 20, 2010||
Jack Keene, Ph.D.
"Coordinated RNA Dynamics in Cancer Cells"
At right: Dr. Bret Hassel (sponsor), Dr. Kevin Cullen and Dr. Jack Keene
Steven M. Frisch, Ph.D.
“A Novel Pathway for the Regulation of Anoikis by EMT"
At right: Dr. Stuart Martin (sponsor), Dr. Steven Frisch, Dr. Kevin Cullen
Larry Norton M.D.
"Self-Seeding: A New Model of Malignant Growth"
At right: Dr. Anne Hamburger, Dr. Larry Norton, Dr. Kevin Cullen
Carl H. June, M.D.
"Adoptive T Cell Transfer Therapy: Genie Out of the Bottle?"
At right: Dr. Aaron Rapoport, Dr. Carl June, Dr. Kevin Cullen
Richard A. Van Etten, M.D., Ph.D.
"Insights into the Pathogenesis and Therapy of Myeloproliferative Neoplasms Through Studies in Mice"
At right: Dr. Richard Van Etten, Dr. Feyruz Rassool, and Dr. Kevin Cullen
Vishva M. Dixit, M.D.
“Ubiquitin Modification in Cancer Signaling Pathways"
At right: Dr. Stuart Martin (sponsor), Dr. Vishva M. Dixit, Dr. Kevin Cullen